tiprankstipranks
Nova Leap Health Corp (TSE:NLH)
:NLH
Canadian Market
NLH
Nova Leap Health
RESEARCH TOOLSreports

Nova Leap Health (NLH) Ratios

14 Followers

Nova Leap Health Ratios

TSE:NLH's free cash flow for Q4 2025 was $0.37. For the 2025 fiscal year, TSE:NLH's free cash flow was decreased by $ and operating cash flow was $0.03. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.96 0.96 1.06 1.59 1.00
Quick Ratio
 0.96 0.96 1.06 1.59 1.00
Cash Ratio
 0.40 0.40 0.43 0.50 0.32
Solvency Ratio
 0.15 0.15 0.47 -0.19 0.10
Operating Cash Flow Ratio
 0.41 0.38 0.43 1.21 0.26
Short-Term Operating Cash Flow Coverage
 0.69 0.64 1.05 10.35 0.43
Net Current Asset Value
$ -846.41K$ -846.41K$ -719.63K$ 142.17K$ -1.29M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.12 0.11 0.07 0.17
Debt-to-Equity Ratio
 0.15 0.15 0.14 0.08 0.21
Debt-to-Capital Ratio
 0.13 0.13 0.12 0.07 0.18
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.01 0.00 <0.01
Financial Leverage Ratio
 1.23 1.23 1.23 1.15 1.28
Debt Service Coverage Ratio
 0.49 0.74 1.45 3.70 0.30
Interest Coverage Ratio
 3.11 3.16 8.08 3.18 -4.06
Debt to Market Cap
 0.10 0.13 0.09 0.01 0.17
Interest Debt Per Share
 0.04 0.04 0.03 0.02 0.05
Net Debt to EBITDA
 1.10 0.73 0.45 0.51 6.41
Profitability Margins
Gross Profit Margin
38.99%37.03%38.38%37.31%35.37%
EBIT Margin
1.47%3.51%7.45%1.76%-3.32%
EBITDA Margin
4.08%6.16%9.71%3.80%1.49%
Operating Profit Margin
3.45%3.51%3.35%1.76%-3.90%
Pretax Profit Margin
-0.41%-0.42%7.03%-5.22%-4.28%
Net Profit Margin
-0.60%-0.60%5.35%-4.03%-2.96%
Continuous Operations Profit Margin
-0.60%-0.60%5.35%-4.03%-2.96%
Net Income Per EBT
144.41%143.78%76.07%77.21%69.27%
EBT Per EBIT
-11.94%-11.94%209.79%-296.86%109.73%
Return on Assets (ROA)
-0.81%-0.82%6.16%-5.05%-3.49%
Return on Equity (ROE)
-1.02%-1.02%7.55%-5.80%-4.47%
Return on Capital Employed (ROCE)
5.61%5.71%4.51%2.41%-5.51%
Return on Invested Capital (ROIC)
5.04%5.13%3.16%1.81%-3.36%
Return on Tangible Assets
-3.25%-3.30%23.84%-18.40%-12.26%
Earnings Yield
-0.84%-1.09%8.39%-6.01%-5.84%
Efficiency Ratios
Receivables Turnover
 17.46 17.46 15.17 15.85 16.09
Payables Turnover
 13.83 14.69 10.15 13.95 15.56
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 35.32 35.32 26.38 22.03 18.88
Asset Turnover
 1.37 1.37 1.15 1.25 1.18
Working Capital Turnover Ratio
 -156.49 1.30K 41.55 50.06 -205.24
Cash Conversion Cycle
 -5.49 -3.94 -11.90 -3.13 -0.77
Days of Sales Outstanding
 20.90 20.90 24.06 23.03 22.69
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 26.39 24.85 35.95 26.16 23.46
Operating Cycle
 20.90 20.90 24.06 23.03 22.69
Cash Flow Ratios
Operating Cash Flow Per Share
 0.02 0.02 0.02 0.02 0.01
Free Cash Flow Per Share
 0.01 0.02 0.02 0.02 0.01
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.84 1.00 0.98 0.99 0.93
Dividend Paid and CapEx Coverage Ratio
 6.27 0.00 55.52 76.98 14.33
Capital Expenditure Coverage Ratio
 6.27 0.00 55.52 76.98 14.33
Operating Cash Flow Coverage Ratio
 0.52 0.48 0.55 1.54 0.26
Operating Cash Flow to Sales Ratio
 0.05 0.04 0.05 0.08 0.04
Free Cash Flow Yield
5.64%7.95%8.30%12.12%6.63%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -119.08 -92.15 11.92 -16.64 -17.14
Price-to-Sales (P/S) Ratio
 0.71 0.56 0.64 0.67 0.51
Price-to-Book (P/B) Ratio
 1.19 0.94 0.90 0.96 0.77
Price-to-Free Cash Flow (P/FCF) Ratio
 17.75 12.58 12.05 8.25 15.08
Price-to-Operating Cash Flow Ratio
 14.91 12.58 11.83 8.15 14.03
Price-to-Earnings Growth (PEG) Ratio
 0.95 0.81 -0.05 -1.28 0.11
Price-to-Fair Value
 1.19 0.94 0.90 0.96 0.77
Enterprise Value Multiple
 18.50 9.75 7.01 18.15 40.48
Enterprise Value
 24.14M 19.24M 17.55M 18.05M 17.02M
EV to EBITDA
 18.50 9.75 7.01 18.15 40.48
EV to Sales
 0.75 0.60 0.68 0.69 0.60
EV to Free Cash Flow
 18.87 13.60 12.87 8.49 17.92
EV to Operating Cash Flow
 15.86 13.60 12.64 8.38 16.67
Tangible Book Value Per Share
 0.02 0.02 0.02 0.04 0.02
Shareholders’ Equity Per Share
 0.22 0.22 0.21 0.21 0.24
Tax and Other Ratios
Effective Tax Rate
 -0.44 -0.44 0.24 0.23 0.31
Revenue Per Share
 0.37 0.37 0.29 0.30 0.36
Net Income Per Share
 >-0.01 >-0.01 0.02 -0.01 -0.01
Tax Burden
 1.44 1.44 0.76 0.77 0.69
Interest Burden
 -0.28 -0.12 0.94 -2.97 1.29
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.33 0.34 0.33 0.32 0.34
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 0.01
Income Quality
 -7.98 -7.32 1.01 -2.04 -1.22
Currency in USD